Page last updated: 2024-09-04

perifosine and Neoplasm Metastasis

perifosine has been researched along with Neoplasm Metastasis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fichtner, I; Wenzel, J; Zeisig, R1
Fichtner, I; Habedank, S; Haider, W; Wenzel, J; Zeisig, R1
Bendell, JC; Campos, LT; Gardner, L; Hagenstad, C; Hermann, RC; Nemunaitis, J; Richards, DA; Sportelli, P; Vukelja, SJ1
Arlen, PM; Chen, C; Chung, EJ; Dahut, WL; Daniels, A; Figg, WD; Gulley, J; Jones, E; Lee, MJ; Parnes, HL; Posadas, EM; Sparreboom, A; Steinberg, SM; Trepel, JB; Trout, A; Wright, J1
Benson, AB; Levy, DE; Marsh, Rde W; Mitchell, EP; Rocha Lima, CM; Rowland, KM1

Trials

3 trial(s) available for perifosine and Neoplasm Metastasis

ArticleYear
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Double-Blind Method; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Phosphorylcholine

2011
A phase II study of perifosine in androgen independent prostate cancer.
    Cancer biology & therapy, 2005, Volume: 4, Issue:10

    Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Leukapheresis; Male; Middle Aged; Neoplasm Metastasis; Phosphorylcholine; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Treatment Outcome

2005
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
    American journal of clinical oncology, 2007, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antiemetics; Child; Disease Progression; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Patient Selection; Phosphorylcholine; Survival Analysis

2007

Other Studies

2 other study(ies) available for perifosine and Neoplasm Metastasis

ArticleYear
Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation.
    International journal of pharmaceutics, 2009, Mar-31, Volume: 370, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Blood Platelets; Breast Neoplasms; Cell Line, Tumor; Dipyridamole; Drug Combinations; Female; Humans; Liposomes; Lung Neoplasms; Metallothionein 3; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Cells, Circulating; Phosphorylcholine; Platelet Aggregation Inhibitors

2009
Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation.
    Breast cancer research and treatment, 2010, Volume: 121, Issue:1

    Topics: Animals; Antineoplastic Agents; Blood Coagulation; Blood Vessels; Cell Line, Tumor; Dipyridamole; Female; Fibrin; Humans; Liposomes; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Metallothionein 3; Mice; Mice, Nude; Neoplasm Metastasis; Phosphorylcholine; Platelet Aggregation Inhibitors; Xenograft Model Antitumor Assays

2010